Literature DB >> 17196688

Detection of cardiac small vessel disease by adenosine-stress magnetic resonance.

Peter Bernhardt1, Benny Levenson, Alexander Albrecht, Thomas Engels, Oliver Strohm.   

Abstract

BACKGROUND: Patients testing positive for myocardial ischemia but without significant coronary artery (CA) stenosis in coronary angiography (CXA) are characterized as having "small vessel disease" (SVD). The aim of our study was to identify these patients by stress perfusion cardiac magnetic resonance (CMR).
METHODS: 317 patients with suspected myocardial ischemia and clinical indication for CXA were scanned < 72 h before CXA in a whole-body 1.5T scanner. After 3 min of adenosine infusion (140 microg/kg/min), a myocardial first-pass perfusion sequence in 4-5 contiguous short-axis orientations using a Gadolinium-based contrast agent (0.1 mmol/kg) was performed. Images were analyzed qualitatively by two independent and blinded investigators.
RESULTS: Perfusion deficits were detected in 93% of our patients. In 78% of patients with relevant perfusion delay, perfusion deficits extended to > 1/3 of the wall thickness in > or = 2 myocardial segments, persisted for > 5 heartbeats and were regarded as relevant coronary macroangiopathy. All of these patients had significant CA stenosis (60% had luminal narrowing > 70% and 18% had 50-70%). 22% of the patients had perfusion deficits affecting < or = 1/3 of wall thickness with persistence for < or = 5 heartbeats and were regarded as having SVD. None of these patients had a CA stenosis of > 50% or received CA revascularization. These patients more frequently had hypertension (p<0.0001), diabetes (p<0.05) and circumferential perfusion deficits (p<0.0001) than other patients.
CONCLUSION: Stress perfusion CMR allows non-invasive differentiation between patients with significant CA stenosis and patients with SVD caused by hypertension and/or diabetes based on the temporal and spatial extent of perfusion deficits. Patients with SVD more often have diffuse perfusion deficits with shorter persistence than patients with significant CA disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17196688     DOI: 10.1016/j.ijcard.2006.11.008

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  10 in total

1.  Is contrast-enhanced cardiac magnetic resonance imaging at 3 T superior to 1.5 T for detection of coronary artery disease?

Authors:  Thomas Walcher; Katharina Ikuye; Wolfgang Rottbauer; Jochen Wöhrle; Peter Bernhardt
Journal:  Int J Cardiovasc Imaging       Date:  2012-07-24       Impact factor: 2.357

2.  Quantification of myocardial perfusion reserve at 1.5 and 3.0 Tesla: a comparison to fractional flow reserve.

Authors:  Peter Bernhardt; Thomas Walcher; Wolfgang Rottbauer; Jochen Wöhrle
Journal:  Int J Cardiovasc Imaging       Date:  2012-04-04       Impact factor: 2.357

Review 3.  Imaging in hypertensive heart disease.

Authors:  Rajesh Janardhanan; Christopher M Kramer
Journal:  Expert Rev Cardiovasc Ther       Date:  2011-02

4.  Comprehensive adenosine stress perfusion MRI defines the etiology of chest pain in the emergency room: Comparison with nuclear stress test.

Authors:  Jens Vogel-Claussen; Jan Skrok; David Dombroski; Steven M Shea; Edward P Shapiro; Mark Bohlman; Christine H Lorenz; Joao A C Lima; David A Bluemke
Journal:  J Magn Reson Imaging       Date:  2009-10       Impact factor: 4.813

5.  Tolerance and safety of adenosine stress perfusion cardiovascular magnetic resonance imaging in patients with severe coronary artery disease.

Authors:  Theodoros D Karamitsos; Jayanth R Arnold; Tammy J Pegg; Adrian S H Cheng; William J van Gaal; Jane M Francis; Adrian P Banning; Stefan Neubauer; Joseph B Selvanayagam
Journal:  Int J Cardiovasc Imaging       Date:  2008-11-27       Impact factor: 2.357

6.  Assessment of myocardial abnormalities in rheumatoid arthritis using a comprehensive cardiac magnetic resonance approach: a pilot study.

Authors:  Yasuyuki Kobayashi; Jon T Giles; Masaharu Hirano; Isamu Yokoe; Yasuo Nakajima; Joan M Bathon; Joao A C Lima; Hitomi Kobayashi
Journal:  Arthritis Res Ther       Date:  2010-09-13       Impact factor: 5.156

7.  Cardiovascular magnetic resonance in systemic hypertension.

Authors:  Alicia M Maceira; Raad H Mohiaddin
Journal:  J Cardiovasc Magn Reson       Date:  2012-06-11       Impact factor: 5.364

Review 8.  The emerging role of Cardiovascular Magnetic Resonance in the evaluation of hypertensive heart disease.

Authors:  Sophie Mavrogeni; Vasiliki Katsi; Vasiliki Vartela; Michel Noutsias; George Markousis-Mavrogenis; Genovefa Kolovou; Athanasios Manolis
Journal:  BMC Cardiovasc Disord       Date:  2017-05-23       Impact factor: 2.298

Review 9.  Current clinical applications of cardiovascular magnetic resonance imaging.

Authors:  L Scholtz; A Sarkin; Z Lockhat
Journal:  Cardiovasc J Afr       Date:  2014 Jul-Aug       Impact factor: 1.167

10.  Stress perfusion Cardiac Magnetic Resonance in Patients with Antiphospholipid Syndrome.

Authors:  Maria G Tektonidou; Petros P Sfikakis; Genovefa Kolovou; Sophie Mavrogeni
Journal:  Mediterr J Rheumatol       Date:  2018-06-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.